Alpha Cognition (ACOG) Net Income towards Common Stockholders (2023 - 2025)
Alpha Cognition's (ACOG) quarterly Net Income towards Common Stockholders came in at -$6.9 million in Q4 2025, down 18.0% year-on-year from -$8.4 million in Q4 2024, and down 420.18% quarter-over-quarter from -$1.3 million in Q3 2025.
Alpha Cognition (ACOG) Net Income towards Common Stockholders (2023 - 2025) Analysis & Trends
Alpha Cognition's Net Income towards Common Stockholders history runs 3 years deep, the most recent figure standing at -$6.9 million for Q4 2025.
- On a quarterly basis, Net Income towards Common Stockholders fell 18.0% year-over-year to -$6.9 million in Q4 2025; TTM through Dec 2025 was -$20.7 million, a 39.77% decrease from a year earlier, with the FY2025 full-year figure at -$20.7 million, down 39.77% from the prior year.
- Net Income towards Common Stockholders fell to -$6.9 million in Q4 2025 per ACOG's latest filing, from -$1.3 million in the prior quarter.
- Across five years, Net Income towards Common Stockholders topped out at -$1.3 million in Q3 2025 and bottomed at -$10.5 million in Q2 2025.
- The 3-year median for Net Income towards Common Stockholders is -$3.3 million (2023), against an average of -$4.3 million.
- Biggest YoY gain for Net Income towards Common Stockholders was 59.89% in 2025; the steepest drop was 395.81% in 2025.
- Year by year, Net Income towards Common Stockholders stood at -$5.7 million in 2023, then slipped by 1.68% to -$5.8 million in 2024, then fell by 18.0% to -$6.9 million in 2025.
- Per Business Quant, the three latest ACOG Net Income towards Common Stockholders figures stand at -$6.9 million (Q4 2025), -$1.3 million (Q3 2025), and -$10.5 million (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -625.73 |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -14.46 Mn |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 227.36 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 727.20 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | -0.68 |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 472.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | -453.82 Mn |
| 10 | Alpha Cognition | 146.84 Mn | 80.73 Mn | 2.61 Mn | -6.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -6.86 Mn |
| Sep 30, 2025 | -1.32 Mn |
| Jun 30, 2025 | -10.49 Mn |
| Mar 31, 2025 | -2.01 Mn |
| Dec 31, 2024 | -5.81 Mn |
| Sep 30, 2024 | -1.86 Mn |
| Jun 30, 2024 | -2.12 Mn |
| Mar 31, 2024 | -5.00 Mn |
| Dec 31, 2023 | -5.71 Mn |
| Sep 30, 2023 | -3.27 Mn |
| Jun 30, 2023 | -2.73 Mn |